Fresenius Kabi warned healthcare providers in a Dec. 5 letter to stop using certain Ivenix large-volume pumps because of the risk that pneumatic valves installed in some devices could issue a pump ...

FDA has upgraded Fresenius Kabi’s voluntary recall of certain Ivenix Large Volume Pump (LVP) primary administration sets to Class I after the company identified a manufacturing defect that could cause ...

For the third time since 2022, when it purchased infusion pump maker Ivenix for $240 million, Fresenius Kabi has earned a Class I rating from the FDA for a recall of the Ivenix medication delivery ...

Fresenius Kabi has recalled one lot of its Ivenix large volume pump primary administration sets after identifying a manufacturing defect that could cause uncontrolled medication flow. The FDA has ...

Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "ASEAN Infusion Pump - Company Evaluation Report, 2025" report has been added to ResearchAndMarkets.com's offering. The ASEAN Infusion Pump Companies ...